Review




Structured Review

BioNTech pfizer-biontech bnt16b2b2 mrna vaccine
Pfizer Biontech Bnt16b2b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pm38997782-41-11-11
Average 90 stars, based on 1 article reviews
pfizer-biontech bnt16b2b2 mrna vaccine - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
Article Snippet: Larson et al., 2021 , 83/F , Leukocytoclastic vasculitis , 7 , 2nd , Pfizer-BioNTech BNT16B2b2.

Article Title: Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
Article Snippet: Altun et al., 2021 , 38/M , Leukocytoclastic vasculitis , 4 , 1st , Pfizer-BioNTech BNT16B2b2.

Article Title: Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Article Snippet: The culprit COVID-19 vaccine types in the study population included BNT16B2b2 mRNA vaccine (Pfizer-BioNTech) in 35 cases (45.5%), mRNA-1273 vaccine (Moderna) in 23 cases (29.9%), ChAdOx1 nCoV-19 vaccine (AstraZeneca) 17 cases (22.1%), and Ad26.COV2.S vaccine (Johnson & Johnson) in two cases (2.6%).

Article Title: Multiple lung abscesses and cold agglutinin syndrome following coronavirus disease 2019: a case report.
Article Snippet: She had received the fourth dose of COVID-19 vaccination, with the Pfizer-BioNTech BNT16B2b2 mRNA vaccine, 7 months prior to presentation.

Vaccines:

Article Title: Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19.
Article Snippet: .. Although approved mRNA vaccines against COVID-19, such as Pfizer-BioNTech BNT16B2b2 or Moderna mRNA-1273, do not require an adjuvant, mRNA itself can also stimulate the innate immune response and promote immune induction via pattern recognition receptors (the Toll-like receptor (TLR) 3, TLR7 or the retinoid-inducible gene I) [10,11]. ..

Adjuvant:

Article Title: Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19.
Article Snippet: .. Although approved mRNA vaccines against COVID-19, such as Pfizer-BioNTech BNT16B2b2 or Moderna mRNA-1273, do not require an adjuvant, mRNA itself can also stimulate the innate immune response and promote immune induction via pattern recognition receptors (the Toll-like receptor (TLR) 3, TLR7 or the retinoid-inducible gene I) [10,11]. ..

Ointment:

Article Title: Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
Article Snippet: Lladó et al (Spain) , ChAdOx1 (AstraZeneca) , 63; F , First, 9 d , Acitretin 20 mg daily, no follow-up recorded. .. Hunjan et al (United Kingdom) , BNT16B2b2 (Pfizer-BioNTech) , 51; M , First, 3 d; second, a few days , Improvement after 4 mo of acitretin 20 mg daily and topical mometasone 0.1% ointment. ..



Similar Products

90
BioNTech pfizer-biontech bnt16b2b2 mrna vaccine
Pfizer Biontech Bnt16b2b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pm38997782-41-11-11
Average 90 stars, based on 1 article reviews
pfizer-biontech bnt16b2b2 mrna vaccine - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioNTech pfizer-biontech bnt16b2b2
Cases of vasculitis after SARS-CoV-2 vaccination, which have been described in the literature.
Pfizer Biontech Bnt16b2b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pmc10201099-36-14-14
Average 90 stars, based on 1 article reviews
pfizer-biontech bnt16b2b2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Cases of vasculitis after SARS-CoV-2 vaccination, which have been described in the literature.

Journal: Mediterranean Journal of Rheumatology

Article Title: Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine

doi: 10.31138/mjr.34.1.97

Figure Lengend Snippet: Cases of vasculitis after SARS-CoV-2 vaccination, which have been described in the literature.

Article Snippet: Altun et al., 2021 , 38/M , Leukocytoclastic vasculitis , 4 , 1st , Pfizer-BioNTech BNT16B2b2.

Techniques: